Abstract

P2.12-04 Liposomal Irinotecan vs Topotecan in Patients with Small Cell Lung Cancer Who Have Progressed On/After Platinum-Based Therapy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
David R Spigel ... Paul A Bunn
Journal of Clinical Oncology | VOL. 42
David R Spigel, et. al.David R Spigel ... Paul A Bunn
22 Apr 2024
MO01.39 Liposomal Irinotecan in Adults with Small Cell Lung Cancer who Progressed on Platinum-Based Therapy: Subgroup Analyses by Platinum Sensitivity
D.R Spigel ... M Jove
Journal of Thoracic Oncology | VOL. 16
D.R Spigel, et. al.D.R Spigel ... M Jove
01 Jan 2020
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer.
Luis Paz‐Ares ... Xiaopan Yao
Cancer | VOL. 128
Luis Paz‐Ares, et. al.Luis Paz‐Ares ... Xiaopan Yao
23 Feb 2022
Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group
Grace K Dy ... Matthew Maurer
Journal of Thoracic Oncology | VOL. 1
Grace K Dy, et. al.Grace K Dy ... Matthew Maurer
01 Mar 2006
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short Course Consolidation Immunotherapy in Unresectable Stage III Non-Small Cell Lung Cancer
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
04 Jul 2024
Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report
Simone Rossi ... Francesco Gelsomino
Journal of Thoracic Oncology | VOL. -
Simone Rossi, et. al.Simone Rossi ... Francesco Gelsomino
24 Jun 2024
Board of Directors
-
Journal of Thoracic Oncology | VOL. 19
--
01 Jun 2024
Finding One Treatment for All Advanced EGFR-positive NSCLC—An Infinite Task
Edyta Maria Urbanska
Journal of Thoracic Oncology | VOL. 19
Edyta Maria UrbanskaEdyta Maria Urbanska
01 Jun 2024
View more papers